Washington, DC -- New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback